SelectScience InterviewsLife Sciences

Standardizing Secondary Phenotype Image Analysis with PerkinElmer’s High Content Profiler

18 Jul 2017
Standardizing Secondary Phenotype Image Analysis with PerkinElmer’s High Content Profiler

Dr. Christopher Hale from Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. In this video, Dr. Christopher Hale advocates the use of PerkinElmer’s High Content Profiler which enables him to standardise his workflow, run quality control on data sets, run principal component analysis and much more. He also discusses how his work is made possible thanks to PerkinElmer’s Operetta and Opera Phenix high content screening systems, which are both easy-to-use and suited to long term assays and confocal imaging.

Opera Phenix High Content Screening System

Revvity

The Opera Phenix ® Plus High-Content Screening System is the premier confocal solution for today' most demanding high content applications. Drawing on over a decade of experience with the industry-leading Opera ® and Opera ® Phenix system, the Opera Phenix Plus is designed for high-throughput high-content assays, phenotypic screening, assays using complex disease models, such as live cells, primary cells and microtissues, and fast-response assays, such as Ca2+ flux.

(3)